Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CMMIE .11x.12 up .05 today :)
Well TELA taking off, that would make eegi shares worth more it would seem
yw
nesk possible 1-150 rs after the name change fwiw
Our board of directors has nominated four persons to serve as directors, each of whom are incumbent directors. The board of directors is also submitting the Aquamatrix, Inc. 2007 Equity Incentive Plan to our stockholders for approval. Additionally, our board of directors has recommended, and we recommend that you approve, an amendment to our articles of incorporation effecting a 1:150 reverse split of the outstanding shares of our common stock. The form of this amendment is included as Appendix A to the enclosed proxy statement. We recommend you vote your shares for the director nominees and in favor of the approval of the 2007 Equity Incentive Plan and the amendment of our articles of incorporation to effect the reverse stock split
So true, IYSA wow .014x.015 :)
IPLY I am hoping we get a pr on the 8k they filed today.
IPLY up on 8K, no pr yet
As of April 4, 2007, the Company entered into, an Asset Purchase Agreement (the
"APA") and a Trademark License Agreement (the "License Back") with Bethesda
Softworks LLC, a video game developer and publisher ("Bethesda"), regarding
"FALLOUT", an intellectual property which was owned by the Company (the "IP").
Although such agreements were signed on April 4, 2007 they were agreed not to be
binding until closing which occurred on April 9, 2007.
Under the APA, the Company sold all of its rights to the IP to Bethesda for a
total amount of $5,750,000.00 payable to the Company, subject to various
conditions, in three cash installments. The first installment of $2,000,000.00
was paid following closing when $200,000.00 was paid to the Company and
$1,800,000.00 was deposited into an escrow account to satisfy various
liabilities. The Company expects to have fulfilled its obligations under the APA
and to receive full payment during the third quarter of 2007. The Company had
previously, on June 29, 2004, entered into, an exclusive licensing agreement
with Bethesda, regarding the IP which was superseded by the APA.
Under the License Back the Company obtained an exclusive license, under certain
conditions, to use the IP for the purpose of developing an Interplay branded
Fallout Massively Multiplayer Online Game ("MMOG").
IPLY 8k out
and patient :)
Thx, my last ride on emxc was wild and profitable, holding for another :)
selling at market, a very BAD mistake, good for us though added at .014 :)
perfect Jim lol
IGXC I have a few of those, patiently waiting :)
hpnn big wall at .04 :)
UCPJ looks as if u were correct
CMMIE new high today on this news fwiw
April 10, 2007 - 8:28 AM EDT
close Email this News Article
Your Name
Your Email
Friend's Name
Friend's Email
Receive Copy: yes
CMMIE 0.055 0.005
Today 5d 1m 3m 1y 5y 10y
CMMI 0.045 0.00
Today 5d 1m 3m 1y 5y 10y
CMMI Settles Lawsuit, Secures Houston Area Fuel Terminal, and Plans Corporate Growth Initiatives
HOUSTON, April 10 /PRNewswire-FirstCall/ -- Consolidated Medical Management, Inc. (OTC Bulletin Board: CMMI) today announced it has filed form 8-K with the U.S. Securities and Exchange Commission announcing settlement of all claims made against it in Cause No. 2005-25849, in the 113th District Court, Harris County, Texas, Patrick Palmer v. North American Reserve Corp., et al., and, as part of the settlement, has leased back the fuel terminal adjacent to Houston's George Bush Intercontinental Airport.
'We are very pleased to have settled this lawsuit as it clears the way for execution of currently planned corporate growth initiatives,' commented Timothy G. Byrd, Sr., Consolidated Medical Management's chief executive officer.
'We have also leased the fuel terminal, with an option to buy, adjacent to Houston's George Bush Intercontinental Airport providing 160,000 barrels of fuel storage capacity, direct access to fuel transmission pipelines, and easy interstate access, all in close proximity to Houston's large oil and gas refineries. We look forward to now moving the company ahead, accelerating operations, securing new customers, and generating shareholder value.
'In addition, to assist the Company with its planned growth initiatives, CapNet Securities, a Houston-based investment banking firm, was also engaged to provide referrals for valuation services, assistance in capital structure and financial planning development, organization of fund-raising for both working capital and capital expenditures, placement agent services for fund- raising activities, and facilitation of mergers and acquisitions,' Byrd concluded.
About Consolidated Medical Management, Inc.
The Company primarily focuses on fuel distribution and fuel terminal operations in the retail and wholesale oil and gas industry sectors. CMMI not only offers storage, delivery, and mixing of petroleum products such as gasoline and diesel fuel, but also offers biodiesel to the growing 'green' fuels market. Biodiesel is a clean burning, nontoxic, sulphur-free, and biodegradable alternative fuel for compression-ignition (diesel) engines made from animal fat or vegetable oil.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered 'forward-looking statements,' generally preceded by words such as 'plans,' 'expects,' 'believes,' 'anticipates,' or 'intends.' We cannot promise future returns. Our statements reflect our best judgment at the time they are issued, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. Consolidated Medical Management, Inc., urges investors to review the risks and uncertainties contained within its filings with the Securities and Exchange Commission.
SOURCE Consolidated Medical Management, Inc.
Source: PR Newswire (April 10, 2007 - 8:28 AM EDT)
News by QuoteMedia
www.quotemedia.com
SPNI's Board has agreed to complete a reorganization of its capital structure in the form of a split that will have one new share exchanged for each 432.3 shares of SPNI now outstanding. The resulting company will have 20,936,193 shares outstanding at the time the merger is complete after giving effect to the reverse split. DEP shareholders will hold newly issued restricted shares representing 94 percent of the outstanding shares of the combined companies.
Yessir :)
The ones that don't lie, many times do not really know the truth of the situation. Sometimes even their lawyers don't.
MGQG .21x.25 getting some buys today fwiw
re eegi folks are so impatient these days imo, good for us. this from a prior post by ed
Posted by: EdFrankie
In reply to: sonslong who wrote msg# 26536 Date:3/31/2007 3:00:14 PM
Post #of 26805
For every share of EEGI you own, you will receive at least one share of TELA as a dividend. So then you will own a free share of TELA yet you will still have your original share of EEGI which will allow you to take part in any future dividends. Per their PR, if certain benchmarks (yet defined) are reached, EEGI shareholders may receive additional TELA shars in the future. Plus, as previously announced, EEGI is planing on divying out their 51% ownership in CTDH per the Mar 1 release.
bought eegi at .10, 5k and it ut
well if u're pounding the table i'm buying :)
bot SCII on ...8k
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 30, 2007
WORLDWIDE BIOTECH & PHARMACEUTICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware
(State or Other Jurisdiction of Incorporation)
01-06914
(Commission File Number)
59-0950777
(I.R.S. Employer Identification Number)
4 Fenghui South Road, Jie Zuo Mansion, 15th Floor, A10-11501
Xi’An, Shaanxi
P.R. China 710075
(Address of principal executive offices, including zip code.)
(8629) 88193339
(Registrant's Telephone Number, Including Area Code)
This Current Report on Form 8-K is filed by Worldwide Biotech & Pharmaceutical Company, a Delaware corporation (the “Registrant”), in connection with the items set forth below.
ITEM 1.01 Entry into a Material Definitive Agreements
ITEM 3.02 Unregistered Sales of Equity Securities
Equity Issuance for Cancellation of Debt Improves Balance Sheet
On March 30, 2007, the Registrant, Xi’An Jin Hao Sci-Tech Investment Management Co., Ltd., a company organized and existing under the laws of the People’s Republic of China (“Jin Hao”), and three foreign investors entered into a Security Purchase Agreement (the “Agreement”) pursuant to which the Registrant sold 10,000,000 shares (the “Shares”) of its common stock to the investors in a transaction intended to be exempt from the registration requirements imposed by the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Regulation S. The shares were sold in exchange for the cancellation of $1.0 million of indebtedness owed to the investors which they acquired from Jin Hao.
According to the Agreement, the Shares are entitled to piggy-back registration rights in the event that the Registrant files a registration statement on Form SB-2 with the Commission. In addition, after a holding period of one year, the Shares may be eligible to be sold pursuant to Rule 144 under the Securities Act, in the event that all of the conditions of the rule are met.
As a result of this issuance by the Registrant, the investors will own approximately 18.5% of the 53,919,653 issued and outstanding shares of common stock of the Registrant in the following proportions: (a) 4,800,000 shares issued to Jianjun Liu, representing 8.9% of the issued and outstanding shares of common stock; (b) 2,650,000 shares issued to Qiang Li, representing 4.9% of the issued and outstanding shares of common stock; and (c) 2,550,000 shares issued to Lan Guo, representing 4.7% of the issued and outstanding shares of common stock. Neither Mr. Liu, Mr. Li nor Ms. Guo intend to hold their shares pursuant to an agreement or understanding, and they do not intend to act in concert. In that connection, Mr. Liu intends to file a Schedule 13D reporting his beneficial ownership of greater than five percent of the issued and outstanding shares of the Registrant, as well as disclosing his investment intent, as soon as practicable, as required by Section 13 under the Securities Exchange Act of 1934, as amended.
The Company is entrusted to register a new product - the Emergency Haemostatic Patch
On March 28, 2007, Yangling Daiying Biotech & Pharmaceutical Group Co., Ltd., a company organized and existing under the laws of the People’s Republic of China and a wholly owned subsidiary of the Registrant (“Yangling Daiying”), and Shaanxi Yangling Daiying Biotech Research Institute, a research institute organized and existing under the laws of the People’s Republic of China (the “Institute”), entered into an Entrusting Agreement (the “Entrusting Agreement”) with respect to the registration and marketing of an Emergency Haemostatic Patch developed by the Institute.
Yangling Daiying is a comprehensive biotech and pharmaceutical company that, among other things, owns 13 GMP-certified medical products production lines, 37 drugs with National Food and Drug Production Approval and 5 nutrient supplements with Food Production Approvals. It focuses both on research, manufacture and sales of biotech and pharmaceutical products and has extensive experience in the registration of medicines and medical devices.
The Institute is a research institute focusing on research and development of biotech and pharmaceutical products, and it has developed many products such as the Emergency Haemostatic Patch. Studies show that the Patch can effectively control various trauma bleeding, and could have widespread applications for emergency care of casualties.
Pursuant to the Entrusting Agreement, Yangling Daiying has agreed to use its best efforts to register the Emergency Haemostatic Patch with the State Food and Drug Administration as a Grade III medical device which is developed and patented in China by the Institute. All expenses associated with the registration process incurred by Yangling Daiying will be paid by the Institute. In addition, Yangling Daiying has been granted the right to purchase no less than 20% of the equity of a new company that is being set up to fund the commercialization of the Patch before Sep. 30, 2007, or purchase the equity of the new company proportionally there after. When the device is manufactured, it will be manufactured in space rented at Yangling Daiying’s facilities.
TCLT seems thin
Does this mean that Ball was finally going to see profits on his technology, and didn't want to include us, --- that thought had crossed mind, wouldn't surprise me.
poster on RB says we have won the lottery with this news and thinks the share price will go to .50 or more! stranger things have happenned, but that seems unlikely. I would like to have some of what he's drinkin though :)
I hope the frog business is huge and profitable and the stock does well for the loyal holders on this board that have been waiting for years GLTA
Sweet, good luck with it, and stay away from 'them twisters'! Very happy here(NW of SA) that we're finally getting some rain. have a geat weekend :)
Hey, as long as something JUMPS, I completely missed DEXTQ, I didn't want to chase it at .01 yesterday,(shows what i know) but i always enjoy watching the madness. "I like ALL stocks that JUMP" amen to that!
ps. enjoy your post, very nice job to keeping everyone informed on breaking news.
LOL :)
Yes, it was my mistake about the price today. I was not trying to pump or draw interest to the stock, I was just saying that the " board very quiet, I think all the shareholders are in shock". I think that rm with a frog farm was a little funny. I do like fried frog legs but doubt it is a huge market.
a thousand pardons, you are correct. wasn't trying to stick anyone in the the ass. I thought the stock was under .02 earlier this week. I see now that there was only a small incease in volume and price on 3/23. This stock has been in my pile for years hoping that one day it would rock on their EVS tech. I doubt anyone will get very excited about a frog farm. :)
AVTX board very quiet, I think all the shareholders are in shock, I know I am lol. Someone somewhere liked the deal i guess since the share price is up a bit. Time will tell :)
Holy Sh*t. I've been in this forever, waiting on this stock to go on their EVS tech and when the stock starts to get some interest I see this: Talk about a change in business. Not many post tonight, is everyone in shock?
AVTX (.024)Signs LOI with Tieli Xiaoxinganlin Frog Breeding Co., Ltd.
Friday, March 30 2007 8:45 PM, GMT-05:00
Business Wire "US Press Releases "
NEW YORK--(BUSINESS WIRE)--
Advance Technologies, Inc. (OTCBB:AVTX) ("AVTX") (the "Company") has signed a Letter of Intent to acquire Tieli Xiaoxinganlin Frog Breeding Co., Ltd., a company registered in the People Republic of China that is a wholly owned subsidiary of American SXAN Biotech, Inc. ("SXAN"), a Delaware Corporation, on Jan. 23, 2007. The proposed transaction would result in AVTX being controlled by SXAN, and is expected to be accounted for as a "reverse acquisition."
The closing of the merger is contingent on approval from the Board of Directors of AVTX and SXAN along with the satisfactory exchange of due diligence materials between the two parties.
"The acquisition merger of SXAN by AVTX is the first step in the reorganization plan adopted by AVTX Board of Directors, December of 2006. The acquisition of SXAN will add to shareholder value while providing development capital for current operations. Pursuant to the letter of intent, AVTX's present operations would be sold to Gary E. Ball and possibly others for its appraised fair market value." stated Mr. Gary E. Ball, CEO of AVTX.
"We believe once we close the merger with AVTX, SXAN will be in a prime position to access the US capital markets and therefore be one step closer toward its ultimate goal of becoming the leading frog breeding company in Asia," stated Mr. Feng Zhenxing, Chairman and CEO of Tieli Xiaoxinganlin Frog Breeding Co., Ltd."
ABOUT Advance Technologies, Inc. (Other OTC: AVTX - News)
Advance Technologies, Inc. engages in the development and license of infrared imaging systems for commercial market applications. It offers enhanced vision systems, infrared security systems, recreational vehicle systems, and medical systems for the security, medical, and transportation markets in the United States. Advance Technologies, Inc. also offers a range of consulting services. The company was founded in 1969 as PWB Industries, Inc. It changed its name to Advance Technologies, Inc. in 1997. The company is based in The Woodlands, Texas.
ABOUT Tieli Xiaoxinganlin Frog Breeding Co. Ltd. (SXAN)
The company, located in Tilie, Yichun City of Helongjiang province, was registered under the law of the Republic of China. After 7 years of research and development, the company has become one of the first enterprises with genetic breeding technology for China's forest frogs. With this technology, the company have applied and been granted national patents for forest frog-derived nutritional supplemental products, including wines and tonics.
Certain of the statements made herein constitute forward-looking statements that involve risks and uncertainties. In such instances, actual results could differ materially as a result of a variety of factors including the risks associated with the effect of changing economic conditions at home and abroad, variations in cash flow, reliance on collaborative retail partners, and on new product development, variations in new product and service development, risks associated with rapid technological change, and potential of introduced or undetected flaws and defects in products and services and other risk factors detailed in forms filed with the Securities and Exchange Commission from time to time.
Source: Advance Technologies, Inc.
Nice job this week Pat, have a great weekend
ALRY ALERT, you get back in after this post Posted by: energymanNJ
In reply to: None Date:3/29/2007 10:12:06 AM
Post #of 136426
ALRY >>>> I think the D word is in effect here Proceed with caution...plus they banned me in my sleep last night...lol
you know what that means
yw
It's on the daily list
ivrc 1-25 rs coming fwiw
oops still not many :)